AI Portfolio Summary
In 2025 Q4, CM Management, LLC maintained a portfolio of 71 distinct positions. The most significant new addition to the portfolio was ALEXANDRIA REAL ESTA, which now represents 1.24% of the total fund value. They heavily accumulated shares in BGC GROUP INC, increasing their position by 14.3%. The fund also reduced its exposure to ARKO CORP by 42.9%.
Total Positions
71
Quarter
2025 Q4
Top Holding
RIGL (8.1%)
Top 10 Concentration
45.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 71
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RIGL
RIGEL PHARMACEU...
|
Healthcare | 8.12% | 5.31% |
#1
2
Prev: #3
|
6.2 | no change | no change |
P
S
|
225,000 | $9,636,750 |
$16.23
+157.8%
|
2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
TGB
TASEKO MINES LT...
|
Basic Materials | 8.11% | 6.52% |
#2
1
Prev: #1
|
5.2 | -150,000 | -8.1% |
P
S
|
1,700,000 | $9,622,000 |
$1.32
+355.3%
|
2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
ALCO
ALICO INC
|
Consumer Defensive | 6.13% | 6.21% |
#3
1
Prev: #2
|
4.0 | -15,000 | -7.0% |
P
S
|
200,000 | $7,276,000 |
$27.07
+35.7%
|
2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 4.44% | 2.96% |
#4
2
Prev: #6
|
2.8 | -80,000 | -17.8% |
P
S
|
370,000 | $5,268,800 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PLPC
PREFORMED LINE ...
|
Industrials | 4.36% | 4.58% |
#5
1
Prev: #4
|
2.7 | -3,000 | -10.7% |
P
S
|
25,000 | $5,167,750 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLGT
RADIANT LOGISTI...
|
Industrials | 3.47% | 3.69% |
#6
1
Prev: #5
|
1.9 | -100,000 | -13.3% |
P
S
|
650,000 | $4,114,500 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BGC
BGC GROUP INC
|
Financial Services | 3.01% | 2.76% |
#7
2
Prev: #9
|
3.2 | 50,000 | 14.3% |
P
S
|
400,000 | $3,572,000 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NMRK
NEWMARK GROUP I...
|
Real Estate | 2.78% | 2.95% |
#8
1
Prev: #7
|
2.1 | no change | no change |
P
S
|
190,000 | $3,294,600 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INTT
INTEST CORP
|
Technology | 2.63% | 2.74% |
#9
1
Prev: #10
|
1.6 | -3,094 | -0.7% |
P
S
|
417,500 | $3,118,725 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CHRS
COHERUS BIOSCIE...
|
Healthcare | 2.51% | 2.87% |
#10
2
Prev: #8
|
2.0 | no change | no change |
P
S
|
2,100,000 | $2,982,000 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 2.44% | 1.47% |
#11
12
Prev: #23
|
4.0 | 25,000 | 50.0% |
P
S
|
75,000 | $2,898,000 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGAU
CENTERRA GOLD I...
|
Basic Materials | 2.42% | 1.79% |
#12
6
Prev: #18
|
2.0 | no change | no change |
P
S
|
200,000 | $2,874,000 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KDP
KEURIG DR PEPPE...
|
Consumer Defensive | 2.36% | 1.70% |
#13
6
Prev: #19
|
3.4 | 20,000 | 25.0% |
P
S
|
100,000 | $2,801,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTRS
VIATRIS INC
|
Healthcare | 2.10% | 2.06% |
#14
Prev: #14
|
0.8 | -50,000 | -20.0% |
P
S
|
200,000 | $2,490,000 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HZO
MARINEMAX INC
|
Consumer Cyclical | 2.04% | 2.11% |
#15
4
Prev: #11
|
1.8 | no change | no change |
P
S
|
100,000 | $2,423,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PK
PARK HOTELS RES...
|
Real Estate | 1.98% | 2.08% |
#16
3
Prev: #13
|
1.8 | no change | no change |
P
S
|
225,000 | $2,353,500 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RBCAA
REPUBLIC BANCOR...
|
Financial Services | 1.86% | 1.93% |
#17
Prev: #17
|
1.7 | no change | no change |
P
S
|
32,000 | $2,207,680 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TALO
TALOS ENERGY IN...
|
Energy | 1.86% | 2.00% |
#18
2
Prev: #16
|
0.7 | -50,000 | -20.0% |
P
S
|
200,000 | $2,204,000 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COYA
COYA THERAPEUTI...
|
Healthcare | 1.71% | 1.43% |
#19
6
Prev: #25
|
2.7 | 50,000 | 16.7% |
P
S
|
350,000 | $2,030,000 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PD
PAGERDUTY INC
|
Technology | 1.66% | 1.65% |
#20
Prev: #20
|
3.2 | 30,000 | 25.0% |
P
S
|
150,000 | $1,966,500 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARKO
ARKO CORP
|
Consumer Cyclical | 1.53% | 2.10% |
#21
9
Prev: #12
|
0.6 | -300,000 | -42.9% |
P
S
|
400,000 | $1,816,000 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GUTS
FRACTYL HEALTH ...
|
Healthcare | 1.48% | 0.80% |
#22
26
Prev: #48
|
3.1 | 200,000 | 33.3% |
P
S
|
800,000 | $1,760,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EOLS
EVOLUS INC
|
Healthcare | 1.40% | 1.28% |
#23
7
Prev: #30
|
1.6 | no change | no change |
P
S
|
250,000 | $1,662,500 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IOSP
INNOSPEC INC
|
Basic Materials | 1.29% | 0.77% |
#24
26
Prev: #50
|
3.5 | 8,000 | 66.7% |
P
S
|
20,000 | $1,530,800 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARKR
ARK RESTAURANTS...
|
Consumer Cyclical | 1.27% | 1.34% |
#25
1
Prev: #26
|
1.5 | no change | no change |
P
S
|
225,000 | $1,508,625 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGNT
COGNYTE SOFTWAR...
|
Technology | 1.27% | 1.12% |
#26
8
Prev: #34
|
1.5 | no change | no change |
P
S
|
160,000 | $1,504,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRGY
CRESCENT ENERGY...
|
Energy | 1.24% | 1.30% |
#27
Prev: #27
|
1.5 | no change | no change |
P
S
|
175,000 | $1,468,250 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARE
ALEXANDRIA REAL...
|
Real Estate | 1.24% | — |
#28
Prev: #—
|
4.0 | 30,000 | no change |
NEW
|
30,000 | $1,468,200 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTOL
BRISTOW GROUP I...
|
Energy | 1.23% | 0.90% |
#29
14
Prev: #43
|
3.0 | 10,000 | 33.3% |
P
S
|
40,000 | $1,464,800 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OGN
ORGANON & CO CO...
|
Healthcare | 1.21% | 2.00% |
#30
15
Prev: #15
|
1.0 | -25,000 | -11.1% |
P
S
|
200,000 | $1,434,000 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
THFF
FIRST FINL CORP...
|
Financial Services | 1.15% | 1.06% |
#31
5
Prev: #36
|
1.5 | no change | no change |
P
S
|
22,500 | $1,359,450 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LYB
LYONDELLBASELL ...
|
Basic Materials | 1.10% | 0.41% |
#32
28
Prev: #60
|
3.4 | 20,000 | 200.0% |
P
S
|
30,000 | $1,299,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHLB
BEACON FINANCIA...
|
Unknown | 1.07% | 1.49% |
#33
11
Prev: #22
|
0.4 | -27,300 | -36.1% |
P
S
|
48,300 | $1,273,671 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVIR
ATEA PHARMACEUT...
|
Healthcare | 1.07% | 1.21% |
#34
1
Prev: #33
|
0.4 | -145,000 | -29.0% |
P
S
|
355,000 | $1,267,350 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SMG
SCOTTS MIRACLE ...
|
Basic Materials | 0.98% | 0.95% |
#35
7
Prev: #42
|
1.4 | no change | no change |
P
S
|
20,000 | $1,167,000 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLPT
CLEARPOINT NEUR...
|
Healthcare | 0.92% | 1.45% |
#36
12
Prev: #24
|
1.4 | no change | no change |
P
S
|
80,000 | $1,094,400 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRCE
1ST SOURCE CORP
|
Financial Services | 0.92% | — |
#37
Prev: #—
|
3.9 | 17,500 | no change |
NEW
|
17,500 | $1,093,575 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 0.92% | 1.27% |
#38
7
Prev: #31
|
0.4 | -300,000 | -42.9% |
P
S
|
400,000 | $1,092,000 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SABR
SABRE CORP
|
Technology | 0.92% | 1.22% |
#39
7
Prev: #32
|
1.4 | no change | no change |
P
S
|
800,000 | $1,088,000 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XOMA
XOMA CORP DEL
|
Healthcare | 0.90% | 1.54% |
#40
19
Prev: #21
|
0.9 | -8,000 | -16.7% |
P
S
|
40,000 | $1,063,600 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DIT
AMCON DISTRG CO
|
Consumer Defensive | 0.84% | 0.85% |
#41
5
Prev: #46
|
1.3 | no change | no change |
P
S
|
9,000 | $997,200 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 0.83% | 1.30% |
#42
14
Prev: #28
|
2.3 | 50,000 | 8.3% |
P
S
|
650,000 | $981,500 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
HRTX
HERON THERAPEUT...
|
Healthcare | 0.82% | 0.79% |
#43
6
Prev: #49
|
1.3 | no change | no change |
P
S
|
750,000 | $975,000 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EEFT
EURONET WORLDWI...
|
Technology | 0.80% | 1.28% |
#44
15
Prev: #29
|
0.3 | -5,000 | -28.6% |
P
S
|
12,500 | $951,375 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMCO
COLUMBUS MCKINN...
|
Industrials | 0.80% | — |
#45
Prev: #—
|
3.8 | 55,000 | no change |
NEW
|
55,000 | $948,750 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTSO
CYTOSORBENTS CO...
|
Healthcare | 0.80% | 1.00% |
#46
7
Prev: #39
|
2.3 | 188,372 | 14.6% |
P
S
|
1,476,500 | $943,779 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NWL
NEWELL BRANDS I...
|
Consumer Defensive | 0.63% | 0.44% |
#47
11
Prev: #58
|
3.3 | 100,000 | 100.0% |
P
S
|
200,000 | $744,000 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SVC
SERVICE PPTYS T...
|
Bond/Debt | 0.62% | 0.68% |
#48
4
Prev: #52
|
2.7 | 100,000 | 33.3% |
P
S
|
400,000 | $736,000 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LTRN
LANTERN PHARMA ...
|
Healthcare | 0.57% | 0.82% |
#49
2
Prev: #47
|
1.2 | no change | no change |
P
S
|
225,000 | $681,750 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PROF
PROFOUND MED CO...
|
Healthcare | 0.53% | — |
#50
Prev: #—
|
3.7 | 80,000 | no change |
NEW
|
80,000 | $629,600 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-50 of 71 holdings